I migliori medici per il trattamento di Sarcoma - TOP-107 medici

Il professor Bülent Karagöz è specializzato in sarcoma con oltre 20 anni di esperienza, concentrandosi sulla biologia dei tumori e sull'immunoterapia presso l'Anadolu Medical Center.

• Capo dell'Oncologia Medica presso l'Ospedale di Formazione GATA Haydarpaşa
• Professore presso la Facoltà di Medicina dell'Università Okan di Istanbul
• Autore di oltre 40 pubblicazioni nella ricerca sul cancro
• Membro della Turkish Medical Oncology Association

Specializzato in oncologia medica presso il Centro Medico Anadolu. Esperto in chemioterapia e terapie mirate.

• Ha completato la formazione specialistica in oncologia medica presso l'Università di Marmara
• Ex responsabile dell'unità di oncologia medica presso l'Ospedale di Formazione e Ricerca Haydarpaşa Numune
• Ha partecipato a studi di ricerca clinica internazionali
• Classificato al 3º posto nell'esame di specialità minore in Turchia

Mustafa Solak ha eseguito oltre 1.100 trattamenti per il cancro e si è formato presso il MD Anderson Cancer Center – uno dei principali istituti di oncologia al mondo.

• 18 anni di esperienza in oncologia clinica
• Specializzato in tumori al seno, al polmone e gastrointestinali
• Formazione specialistica presso l'Istituto dei tumori dell'Università di Hacettepe
• Ex membro del personale presso il prestigioso MD Anderson Cancer Center

Responsabile dell'Unità Sarcomi presso il Centro Medico Teknon — il Dr. Galceran ha eseguito oltre 1.200 trattamenti per sarcomi.

• 38 anni di specializzazione in oncologia con un focus sui sarcomi
• Guida l'Unità dei Tumori Genitourinari, SNC, Sarcomi e Tumori di Origine Sconosciuta presso l'Ospedale Universitario Vall d'Hebron
• Membro del Gruppo Spagnolo di Ricerca sui Sarcomi (GEIS)
• Ha pubblicato oltre 120 articoli peer-reviewed su argomenti oncologici
• Riconosciuto come uno dei principali esperti in Spagna nel trattamento dei sarcomi

Assoc. Prof. Gorkem Turkkan started his medical education at Gülhane Military Medical Academy in 2003 and completed it at Zonguldak Karaelmas (Bülent Ecevit) University Faculty of Medicine in 2009. He completed his specialization at Trakya University Faculty of Medicine, Department of Radiation Oncology and became a radiation oncology specialist in 2016.

After completing his compulsory service, he served as a Lecturer and Head of Department at Muğla Sıtkı Koçman University Faculty of Medicine, Department of Radiation Oncology, from May 2019 to February 2021. Meanwhile, between March and June 2020, he worked as a clinical researcher at Maastricht University Faculty of Medicine Department of Radiation Oncology – MAASTRO Clinic (Netherlands) on stereotactic radiotherapy, thoracic radiotherapy-related lung toxicity and proton therapy. While he was working at İstinye University Faculty of Medicine, Department of Radiation Oncology and Liv Hospital Ulus Radiation Oncology Clinic between March 2021 and April 2023, he received the title of Associate Professor in February 2023. She has been serving her patients at Hisar Hospital Intercontinental since May 2023.

He has performed both traditional radiotherapy and advanced radiotherapy throughout his career. He is one of the experienced physicians in our country in stereotactic radiotherapy and MRI-guided radiotherapy treatments, which have become increasingly popular and used especially recently. So far, he has successfully completed more than 2500 radiotherapy sessions with the MR-Linac device.

He has been a member of the Turkish Society of Radiation Oncology (TROD) since 2013 and the European Society of Radiotherapy and Oncology (ESTRO) since 2015. He has 27 articles published in domestic and international journals, 31 oral-poster presentations presented at national and international congresses, and 5 book chapters published by national and international publishing houses. He taught Term I and Term V undergraduate courses at Muğla Sıtkı Koçman University Faculty of Medicine, postgraduate courses within the scope of Ear Nose and Throat Department Specialization training, and Radiotherapy associate degree courses at İstinye University Vocational School of Health Services. She is currently working on 2 ongoing TÜBİTAK Projects. He is married and has a son.

MEDICAL INTERESTS

MR-Linac

Linac

Stereotactic (Pinpoint) Radiotherapy

Prostate Cancers

Breast Cancers

Lung Cancers

Rectum Cancers

Brain and Spinal Cord Cancers

Head and Neck Cancers

Volumetric Arc Therapy (VMAT)

Intensity Modulated Radiotherapy (IMRT)

Esperienza lavorativa

• Maggio 2006 - Ottobre 2007: Ospedale Statale di Urgup (servizio obbligatorio in specialità "Ostetricia e Ginecologia")
• Luglio 2008 - Luglio 2009: Ospedale Militare di Edremit (servizio militare)
• Novembre 2009 - Aprile 2015: Ospedale Universitario di Başkent ad Adana, reparto di ostetricia e ginecologia
• Maggio 2015 - Maggio 2018: Programma di specializzazione in oncologia ginecologica, Università di Marmara
• Luglio 2018 - Settembre 2024: Ospedale di Ricerca e Formazione di Ümraniye
• Dicembre 2024 - presente: Centro Medico Anadolu

Esperienza lavorativa all'estero

• Agosto 2009 - Novembre 2009: Centro Medico Tel-Hashomer Sheba, ISRAELE
• Luglio 2014: Clinica Asklepios, AMBURGO, GERMANIA
• Febbraio 2018 - Marzo 2018: Ospedale Charité, BERLINO, GERMANIA

Istruzione

• Post-dottorato in Medicina: Università di Marmara, reparto di oncologia ginecologica, 2015–2018, Istanbul
• Specializzazione in Medicina: Università di Başkent, Facoltà di Medicina, reparto di ostetricia e ginecologia, 2001–2006, Ankara
• Facoltà di Medicina: Università di Istanbul, Facoltà di Medicina di Cerrahpaşa, 1994–2000, Istanbul

Aree di specializzazione

• Chirurgia nell'oncologia ginecologica e altre procedure ginecologiche di base e avanzate. Particolare interesse per interventi che preservano la fertilità, interventi laparoscopici e robotizzati.

Iscrizione a comunità professionali

• ESGO - Società Europea di Oncologia Ginecologica (membro dal 2015)
• TRSGO - Società Turca di Oncologia Ginecologica (membro dal 2016)

Il Professor Merimsky guida il Dipartimento di Tumori delle Ossa e dei Tessuti Molli presso il Sourasky Medical Center, specializzandosi nel trattamento del sarcoma con oltre 25 anni di esperienza.

• Formazione in trattamento del sarcoma presso l'Institut Gustave Roussy, Parigi
• Presidente della Società Israeliana di Oncologia Clinica e Radioterapia
• Membro attivo del gruppo ESMO Sarcoma e ASCO
• Ha pubblicato ampiamente su ricerca in sarcoma e oncologia

Dr. Mehmet Taner Ozdemir is an experienced orthopedic specialist with 7 years in the field. He focuses on oncology, orthopedic trauma, arthroscopic surgery, and bone and soft tissue tumors. He completed his medical and specialist training at GATA Faculty of Medicine in Ankara. He also received advanced training at the Hospital for Special Surgery in New York, USA.

Dr. Ozdemir is a member of the Turkish Orthopedics and Traumatology Association and the European Musculoskeletal Tumor Society. He has written five national and thirteen international publications. He is dedicated to improving orthopedic science. His skills include joint replacements, arthroscopies, and tumor surgeries.

Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.

Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.

Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.

Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.

Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.

Doctor Brenda Pastrana is a mexican surgical Oncologist. 

Medical background.

Centro Medico Nacional 20 de Noviembre Issste, Surgical Oncologist in 2020.

Title by Universidad Autónoma de México UNAM.

Surgical Residency Instituto Mexicano del Seguro Social. 2015.

Title by Universidad de Quintana Roo. 

Board Certified by Conacem from 2020 to 2025 number 2171 

Board Certified by Conacem from 2025 to 2030 number 2171

Member of SMEO. Sociedad Mexicana de Oncología. 

University teacher at Universidad Anahuac of Medicine since 2020.

Ricercatore principale di studi clinici sulle terapie oncologiche – Il Dr. Sarid porta trattamenti all'avanguardia al Sourasky Medical Center.

• Oltre 15 anni come oncologo senior presso Sourasky (Ichilov)
• Specializzato in chemioterapia, radioterapia e terapie biologiche
• Autore di oltre 30 articoli sul trattamento del cancro
• Docente presso l'Università di Tel Aviv
• Membro di ESMO e ASCO

Il Professor Dr. Mehmet Karaca è specializzato in tumori ginecologici da oltre 20 anni, con competenze in chirurgia laparoscopica e gravidanze ad alto rischio.

• Professore di Ginecologia e Ostetricia con un dottorato di ricerca presso l'Università di Dicle
• Formazione in chirurgia oncologica ginecologica minore dal Ministero della Salute
• Membro della facoltà presso le Università di Akdeniz e Kafkas
• Oltre un decennio di ruoli dirigenziali in importanti ospedali

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Head of Teaching at the Puerto Vallarta Regional Hospital

2020-2023

Medical records manager at the Regional Hospital of Puerto Vallarta 2 months 2020

General practitioner in private medical office

2015-2022

Doctor in charge of weight control clinic

2013-2014

Medical assistant in dermatology clinic

2008-2013

Medical Assistant in Dermatological procedures.

 Medical Assistant in minimally invasive surgical procedures

 Operation of fractional laser machine - IPIXEL-ER and

facial rejuvenation with IPL.

 Experience in laser hair removal with Intense Pulsed Light and

radiofrequency

 Experience with ultrasonic cavitation

 Experience with ultraviolet (UV) light phototherapy machine for the

treatment of psoriasis and vitiligo.

 Experience assisting in Botox and Fillers procedures.

 Biomagnet certified by the Higher Institute of Biomagnetism

doctor ISAAC GOIZ DURAN

 Experience in clinical records

 Training in continuing education and professional development of teachers

Personal Information 

Sex:  Male

Born : 1968 

Professional Experience

Gayrettepe Florence Nigthingale Hospital

Medical Oncology Department

Besiktas/Istanbul/Turkey (ongoing)

Education:

He became Professor (22/April /2016)

Medical Oncology

Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)

Istanbul University Oncology Institue,

Department of Medical Oncology

Medical Oncology Fellowship (December 2001-December2004)

Istanbul University, Istanbul Medical Faculty

Hemodialysis Traning (May1996-January1997)

Istanbul University ,bCerrahpasa Medical Faculty

Internal Medicine Residency (November 1991-November 1996)

Istanbul University ,bCerrahpasa Medical Faculty

Ege University Medical Faculty (1985-1991)

Professional Experience

February 1999-November 2001

Metropolitan Florence Nigthingale Hospital

American Cancer Center, Gayrettepe/İstanbul

April1997- October 1998

Bayraktar Dialysis Center

Güngören/ Istanbul

Membership

Turkish Medical Oncology Association

ENET(European Neuroendocrine Tumour Society)

ESMO

ASCO

Activities • Prevention, research and early diagnosis of cancer • Palliative care in cancer • Cytotoxic chemotherapy • Hormontherapy • Targeted treatment • Immunotherapy Education • 2004 -2010 - Istanbul University, Istanbul faculty of medicine • 2011-2015 - Istanbul University, Istanbul faculty of medicine, internal medicine specialist • 2013-2014 - Cleveland Clinic Endocrinology Department, research associate • 2016-2019 Bezmiâlem Foundation University Medical Oncology Subdivision • Dissertation: Prognostic value of absolute monocyte count in patients with mantle cell lymphoma. • Subdivision Dissertation: An effect of adjuvant chemotherapy on lipid profile and anthropometric parameters in patients with breast and colon cancer. Publications • Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggressiveness in Patients with Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M, et al. Endocr  18. • The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer. • Aliyev A, Soundararajan S, Bucak E et al. Surgery.  • Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9. • Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat. Epub 2018 Aug 20. • Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan; Epub 2018 Oct 30. • Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: currproblcancer.2019.06.009. • Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal. • Oral presentations 

Personal information

Title: Professor Doctor

Branch: Radiation Oncology

Work History:

1 GATA Military Medical Faculty

2 Gayrettepe Florence Nightingale Hospital

3 T.R. Demiroğlu Bilim University \ Associate Professor

4 T.R Demiroğlu Bilim University \ Professor

Medical Specialties and Subspecialties:

1 Head and Neck Cancers

2 Radiation Oncology

Priority treatments:

1 Prostate cancer

2 Conformal treatments

Special advanced health technologies:

1 Truebeam Stx Technology

2 Halcyons

Education

1991 - Istanbul University Istanbul Faculty of Medicine

1996 - Istanbul University Cerrahpaşa Faculty of Medicine Radiation

Oncology Specialization Training

Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.

He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.